Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity

Blood Adv. 2022 Jul 26;6(14):4157-4161. doi: 10.1182/bloodadvances.2021006833.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Casein Kinase Idelta* / metabolism
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use
  • Protein Processing, Post-Translational

Substances

  • Protein Kinase Inhibitors
  • Casein Kinase Idelta